Home » Topics » BioWorld Science

BioWorld Science
RSS

Sanofi seeks EMA review of fexinidazole for sleeping sickness

Jan. 31, 2018

Inoperable HCC patients on tivozanib show durable tumor responses

Jan. 31, 2018

Phase III trial of sublingual apomorphine meets endpoints in patients with Parkinson's disease

Jan. 31, 2018

BridgeBio establishes QED Therapeutics to drive development of newly licensed infigratinib

Jan. 31, 2018

Kancera discovers ROR1 inhibitors

Jan. 31, 2018

European approval of Prevymis triggers milestone payment to AiCuris

Jan. 31, 2018

InnoCare Pharma divulges novel FGFR inhibitors for cancer

Jan. 31, 2018

Bayer identifies new muscarinic M2 receptor PAMs

Jan. 31, 2018

Chiesi Farmaceutici discloses new compounds for asthma

Jan. 31, 2018

Roche patents compounds for treating HBV infection

Jan. 31, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 17, 2025
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...